Integrated mechanistic modeling approaches in oncology drug development Webinar Integrated mechanistic modeling approaches in oncology drug development CertaraJuly 8, 2026
AI, HTA, and the future of access: Inside the 12th annual Kraków HTA symposium Blog AI, HTA, and the future of access: Inside the 12th annual Kraków HTA symposium Explore key insights from the 12th Annual Kraków HTA Symposium covering HTA, reimbursement policy, AI…Simona ColucciJuly 8, 2026
Dosimetry for radiopharmaceutical therapy: From measurement to dose justification Blog Dosimetry for radiopharmaceutical therapy: From measurement to dose justification Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…Hunter Stephens, PhDJuly 7, 2026
The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors On-Demand Webinar The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors Learn how PBPK and QSP modeling support faster drug development by enabling smarter dose selection,…CertaraJuly 1, 2026
Enhancing clinical trials with real-world evidence in pregnancy research Blog Enhancing clinical trials with real-world evidence in pregnancy research Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…CertaraJune 26, 2026
Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development Announcement Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development Integrated offering combines drug development, regulatory, commercial, and investor strategy expertise to help early-stage biotech…Danielle PillsburyJune 23, 2026
Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling Poster Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling Authors: Ibtissem Rebai (Certara), Stephen Duffull (Certara), Ayman Akil (Certara), Anna Largajolli (Certara), Floris Fauchet…CertaraJune 22, 2026
Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices Poster Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices Discover how the AI/ML Special Interest Group is advancing responsible artificial intelligence in pharmacometrics through…CertaraJune 22, 2026
Machine Learning based drug renal clearance predictor development and application Poster Machine Learning based drug renal clearance predictor development and application A machine learning QSAR model predicts human renal clearance from simple, easy-to-obtain inputs and sharpens…CertaraJune 22, 2026
Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization Poster Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization Discover how active learning and Bayesian optimization improve virtual population generation for quantitative systems pharmacology…CertaraJune 18, 2026